Neurovascular Diagnostics is developing a low-cost, blood diagnostic to detect unruptured brain aneurysms. This prescreen will lower the cost of aneurysm detection, giving physicians the tools they need to take cost-effective preventative measures, and giving millions of Americans access to affordable screening.